BMO Capital raised the firm’s price target on Azek (AZEK) to $54 from $52 and keeps a Market Perform rating on the shares after its Q1 earnings ...

BMO Capital analyst Brian Pitz raised the firm’s price target on Criteo (CRTO) to $60 from $48 and keeps an Outperform rating on the shares.

Bank of Montreal closed 4.4% short of its 52-week high of C$147.54, which the company reached on December 6th.

February 04, 2025, 08:12 PM ET, BY Robert S., Contributor | Editor: Derek Curry ( Follow on LinkedIn ) ...

BMO Capital Markets maintained their Outperform rating on Axalta Coating Systems (NYSE:AXTA) with a steady price target of ...

BMO Capital Markets maintained its positive stance on Nike stock (NYSE:NKE), increasing the price target from $92.00 to ...

Health experts are seeing signs of a much smaller wave of U.S. COVID-19 cases this winter than in previous years, which could ...

Tariffs, major weather events and even political bias have obscured trends and challenged experts to figure out the takeaways.

As inflation expectations come down, Canadians foresee a reduction in interest rates on loans and savings, according to the BoC. Respondents expect the rate to be 4.5% one year ahead from the fourth ...

BMO Capital Markets sees turbulence picking up in U.S. equities in 2025, and published a list of dividend-growth stocks it said can help investors weather bouts of volatility. Such stocks can aid ...

On Thursday, BMO Capital Markets sustained its positive outlook on AbbVie Inc . (NYSE:ABBV) shares, maintaining an Outperform rating and a $208.00 price target. The firm's analyst, Evan David ...

BMO agreed to pay more than $40.6 million to settle allegations that its capital-markets unit failed to supervise employees who sold mortgage-backed bonds with a misleading composition, the Securities ...